Skip to main content
Log in

Metabolic Effects of Bariatric Surgery in Insulin-Sensitive Morbidly Obese Subjects

  • Clinical Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

The effects of bariatric surgery (BS) in metabolically healthy morbidly obese (MO) subjects are not well established. Against this background, we characterized the metabolic and inflammatory profiles of MO subjects with insulin sensitivity (IS) in the normal range, and evaluated the changes on these parameters following BS in this population.

Methods

We conducted a retrospective analysis of prospectively collected data in MO women undergoing BS between 2006 and 2010. Anthropometric, metabolic comorbidities, and inflammatory markers were compared at baseline and 12 months after BS, between 52 women (10.4 %) presenting with a HOMA-IR <2.94 (80th percentile reference population) (IS-MO group) and an age- and BMI-matched group of women (n = 52) with HOMA-IR >2.94.

Results

The IS-MO women presented a more favorable metabolic and inflammatory profile as compared to the IR-MO group. However, an enlarged waist circumference (WC), a high-sensitivity C-reactive protein (hs-CRP) >3 mg/dL, and metabolic syndrome (MS) were present in 100 %, 90 %, and 51.9 % of the IS-MO group at baseline. At 12 months after surgery, all the MS components and hs-CRP improved in IS-MO subjects (p < 0.01). The prevalence of the MS in the IS-MO group significantly decreased (11 %, p < 0.05) despite WC and hs-CRP being abnormal respectively in 53.3 % and 20.0 % of women in this group.

Conclusions

In MO women, an IS in the normal range is associated with a limited protection from metabolic co-morbidities. Nonetheless, BS results in the amelioration of the altered metabolic and inflammatory profiles also in this group of subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ferrannini E, Haffner SM, Mitchell BD, et al. Hyperinsulinemia: the key feature of cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416–22.

    Article  PubMed  CAS  Google Scholar 

  2. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90:4145–50.

    Article  PubMed  CAS  Google Scholar 

  3. Marini MA, Succurro E, Frontoni S, et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy non obese women and insulin-resistant women. Diabetes Care. 2007;30:2145–7.

    Article  PubMed  Google Scholar 

  4. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906–12.

    Article  PubMed  CAS  Google Scholar 

  5. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile. J Clin Endocrinol Metab. 2001;86:1020–5.

    Article  PubMed  CAS  Google Scholar 

  6. Jennings CL, Lambert EV, Collins M, et al. Determinants of insulin-resistance phenotypes in normal weight and obese Black African women. Obesity. 2008;16:1602–9.

    Article  PubMed  Google Scholar 

  7. Soverini V, Moscatiello S, Villanova N, et al. Metabolic syndrome and insulin resistance in subjects with morbid obesity. Obes Surg. 2010;20:295–301.

    Article  PubMed  Google Scholar 

  8. Shin MJ, Hyun YJ, Kim OY, et al. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond). 2006;30:1529–34.

    Article  CAS  Google Scholar 

  9. Karelis AD, Messier V, Brochu M, et al. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia. 2008;51:1752–4.

    Article  PubMed  CAS  Google Scholar 

  10. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia. 1985;28:412–9.

    Article  PubMed  CAS  Google Scholar 

  11. Vidal J, Morinigo R, Codoceo VH, et al. The importance of diagnostic criteria in the association between metabolic syndrome and cardiovascular disease in obese subjects. Int J Obes. 2005;29:668–74.

    Article  CAS  Google Scholar 

  12. Vidal J, Ibarzabal A, Nicolau J, et al. Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg. 2007;17:1069–74.

    Article  PubMed  CAS  Google Scholar 

  13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35:S64–71.

    Article  Google Scholar 

  14. Grundy SM, Cleeman JI, Daniels S, et al. Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–52.

    Article  PubMed  Google Scholar 

  15. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. Int J Obes. 2010;34:S18–23.

    Article  Google Scholar 

  16. Weiss R, Taksali SE, Dufour S, et al. The “obese insulin-sensitive” adolescent: importance of adiponectin and lipid partitioning. J Clin Endocrinol Metab. 2005;90:3731–7.

    Article  PubMed  CAS  Google Scholar 

  17. Stefan N, Kantartzis K, Macann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609–16.

    Article  PubMed  Google Scholar 

  18. Olefsky JM, Glass CK. Macrophages, inflammation and insulin resistance. Annu Rev Physiol. 2010;72:219–46.

    Article  PubMed  CAS  Google Scholar 

  19. Ardern CL, Janssen I, Ross R, et al. Development of health-related waist circumference thresholds within BMI categories. Obes Res. 2004;12:1094–103.

    Article  PubMed  Google Scholar 

  20. Barbarroja N, López-Pedrera R, Mayas MD, et al. The obesity healthy paradox: is inflammation the answer? Biochem J. 2010;430:141–9.

    Article  PubMed  CAS  Google Scholar 

  21. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–43.

    Article  PubMed  CAS  Google Scholar 

  22. Chang I, Ryu S, Suh BS, et al. Impact of BMI on incidence of metabolic abnormalities in metabolically healthy men. Int J Obes (Lond). 2011. doi:10.1038/ijo.2011.247.

  23. Tschoner A, Sturm W, Engl K, et al. Retinol-binding protein, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity. 2008;16:2439–44.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

As authors of this manuscript, Amanda Jiménez, Verónica Perea, Ricard Corcelles, Violeta Moizé, Antonio Lacy, and Josep Vidal declare that they do not have competing financial interests to disclose in relation to the work described herein.

Disclosure Statement

The authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Josep Vidal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiménez, A., Perea, V., Corcelles, R. et al. Metabolic Effects of Bariatric Surgery in Insulin-Sensitive Morbidly Obese Subjects. OBES SURG 23, 494–500 (2013). https://doi.org/10.1007/s11695-012-0817-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-012-0817-7

Keywords

Navigation